한글목차

핵산 검사 동향과 예측

세계 핵산 검사 시장은 2024년부터 2030년까지 11.2%의 CAGR로 2030년까지 약 67억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 정확하고 신속한 진단 검사에 대한 수요 증가, 혈액 은행 및 수혈 센터의 핵산 검사 키트에 대한 수요 증가, 암, 유전성 질환 및 감염성 질환의 발병률 증가입니다. 세계 핵산 검사 시장의 미래는 병원 및 클리닉, 병리 검사실, 학술 및 연구 기관 시장에서의 비지니스 기회로 인해 유망합니다.

핵산 검사 시장 인사이트

Lucintel의 예측에 따르면, 바이러스 양을 결정하는 데 도움이 되는 유전자형 및 아형 식별을 위한 핵산 검사 키트가 상당히 많이 사용되고 있기 때문에 감염은 가장 큰 부문으로 남아있을 것으로 보입니다.

북미 지역은 인구의 전염병 확산과 핵산 검사 연구개발에 대한 정부의 강력한 지원으로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 시장 부문 중 가장 유망하고 성장성이 높은 분야는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 핵산 검사 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 핵산 검사 시장 동향(2018-2023)과 예측(2024-2030)
• 제품 유형별 세계 핵산 검사 시장
  • 중합효소 연쇄 반응
  • 리가아제 연쇄 반응
  • 전사 매개 증폭
  • 전게놈 배열 결정
  • 기타
• 적응증별 세계 핵산 검사 시장
  • 감염증
  • 암
  • 법의학 검사
  • 맞춤형 의료
  • 기타
• 최종 용도별 세계 핵산 검사 시장
  • 병원과 클리닉
  • 병리 연구소
  • 학술·연구 조직
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 핵산 검사 시장
• 북미의 핵산 검사 시장
• 유럽의 핵산 검사 시장
• 아시아태평양의 핵산 검사 시장
• 기타 지역 핵산 검사 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품 유형별 세계 핵산 검사 시장 성장 기회
  • 적응증별 세계 핵산 검사 시장 성장 기회
  • 최종 용도별 세계 핵산 검사 시장 성장 기회
  • 지역별 세계의 핵산 검사 시장 성장 기회
• 세계의 핵산 검사 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 핵산 검사 시장 능력 확대
  • 세계의 핵산 검사 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

영문목차

Nucleic Acid Testing Trends and Forecast

The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

Nucleic Acid Testing by Segment

The study includes a forecast for the global nucleic acid testing by product type, indication, end use, and region.

Nucleic Acid Testing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Polymerase Chain Reaction
• Ligase Chain Reaction
• Transcription-Mediated Amplification
• Whole Genome Sequencing
• Others

Nucleic Acid Testing Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Disease
• Cancer
• Forensic Testing
• Personalized Medicine
• Others

Nucleic Acid Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Pathology Laboratories
• Academic & Research Organization
• Others

Nucleic Acid Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Nucleic Acid Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nucleic acid testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid testing companies profiled in this report include-

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

Nucleic Acid Testing Market Insights

Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Features of the Global Nucleic Acid Testing Market

Market Size Estimates: Nucleic acid testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nucleic acid testing market size by product type, indication, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, indications, end uses, and regions for the nucleic acid testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the nucleic acid testing market size?

Answer: The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030.

Q.2 What is the growth forecast for nucleic acid testing market?

Answer: The global nucleic acid testing market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the nucleic acid testing market?

Answer: The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

Q4. What are the major segments for nucleic acid testing market?

Answer: The future of the nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets.

Q5. Who are the key nucleic acid testing market companies?

Answer: Some of the key nucleic acid testing companies are as follows:

• F. Hoffmann-La Roche
• Becton and Dickinson
• Danaher
• Abbott Laboratories
• Illumina
• Siemens Healthineers
• bioMerieux

Q6. Which nucleic acid testing market segment will be the largest in future?

Answer: Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

Q7. In nucleic acid testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid testing market by product type (polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, whole genome sequencing, and others), indication (infectious disease, cancer, forensic testing, personalized medicine, and others), end use (hospitals & clinics, pathology laboratories, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nucleic Acid Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nucleic Acid Testing Market by Product Type
  • 3.3.1: Polymerase Chain Reaction
  • 3.3.2: Ligase Chain Reaction
  • 3.3.3: Transcription-mediated Amplification
  • 3.3.4: Whole Genome Sequencing
  • 3.3.5: Others
• 3.4: Global Nucleic Acid Testing Market by Indication
  • 3.4.1: Infectious Disease
  • 3.4.2: Cancer
  • 3.4.3: Forensic Testing
  • 3.4.4: Personalized Medicine
  • 3.4.5: Others
• 3.5: Global Nucleic Acid Testing Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Pathology Laboratories
  • 3.5.3: Academic & Research Organization
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nucleic Acid Testing Market by Region
• 4.2: North American Nucleic Acid Testing Market
  • 4.2.1: North American Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.2.2: North American Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.3: European Nucleic Acid Testing Market
  • 4.3.1: European Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.3.2: European Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.4: APAC Nucleic Acid Testing Market
  • 4.4.1: APAC Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.4.2: APAC Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
• 4.5: ROW Nucleic Acid Testing Market
  • 4.5.1: ROW Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
  • 4.5.2: ROW Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nucleic Acid Testing Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Nucleic Acid Testing Market by Indication
  • 6.1.3: Growth Opportunities for the Global Nucleic Acid Testing Market by End Use
  • 6.1.4: Growth Opportunities for the Global Nucleic Acid Testing Market by Region
• 6.2: Emerging Trends in the Global Nucleic Acid Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nucleic Acid Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F. Hoffmann-La Roche
• 7.2: Becton and Dickinson
• 7.3: Danaher
• 7.4: Abbott Laboratories
• 7.5: Illumina
• 7.6: Siemens Healthineers
• 7.7: bioMerieux